Memorial Sloan Kettering Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma
- First Posted Date
- 2013-01-11
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 18
- Registration Number
- NCT01766739
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
- Conditions
- Cancer Patients First-ever Acute Ischemic Stroke
- Interventions
- First Posted Date
- 2013-01-09
- Last Posted Date
- 2020-08-14
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT01763606
- Locations
- 🇺🇸
New York Presbyterian Hospital, New York, New York, United States
🇺🇸Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering West Harrison, Harrison, New York, United States
Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- Biological: anti-thymocyte globulin (ATG)Procedure: a T cell depleted stem cell transplant
- First Posted Date
- 2013-01-01
- Last Posted Date
- 2025-03-20
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 29
- Registration Number
- NCT01758328
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma
- Conditions
- Neuroblastoma
- Interventions
- Biological: Hu3F8 With GM-CSF
- First Posted Date
- 2012-12-31
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 186
- Registration Number
- NCT01757626
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Image-Guided Navigation for High Dose Rate Temporary Interstitial Brachytherapy in the Palliative Management of Previously Treated Tumors of the Spine and Pelvis
- Conditions
- Metastatic or Recurrent Lesions in the SpineMetastatic or Recurrent Lesions in the Pelvis
- Interventions
- Radiation: Ir-192 high dose rate (HDR)
- First Posted Date
- 2012-12-31
- Last Posted Date
- 2018-03-20
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 3
- Registration Number
- NCT01757717
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and Myeloma
- Conditions
- Multiple MyelomaNon-Hodgkin's Lymphoma
- Interventions
- First Posted Date
- 2012-12-24
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 49
- Registration Number
- NCT01755975
- Locations
- 🇺🇸
Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸Saint Francis/Mount Sinai Regional Cancer Center, Hartford, Connecticut, United States
🇺🇸University of Nebraska Medical Center, Omaha, Nebraska, United States
3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2012-12-18
- Last Posted Date
- 2021-11-19
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 124
- Registration Number
- NCT01751451
- Locations
- 🇺🇸
Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, United States
🇺🇸Memorial Sloan Kettering West Harrison, Harrison, New York, United States
🇺🇸NorthShore University Health System, Long Island City, New York, United States
A Pilot Study of Perihepatic Phlebotomy During Hepatic Resections
- Conditions
- Liver Cancer
- Interventions
- Other: Perihepatic Phlebotomy
- First Posted Date
- 2012-12-13
- Last Posted Date
- 2019-12-03
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 117
- Registration Number
- NCT01749332
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation
- Conditions
- Multiple MyelomaNon-Hodgkin's LymphomaLeukemiaMyelodysplastic Syndrome
- Interventions
- Procedure: peripheral blood stem cell transplantationRadiation: Total-Body Irradiation (TBI)
- First Posted Date
- 2012-12-11
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 82
- Registration Number
- NCT01746849
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2012-12-10
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 23
- Registration Number
- NCT01745588
- Locations
- 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
🇺🇸North Shore LIJ, New Hyde Park, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States